Xenon Pharmaceuticals (XENE)
(Delayed Data from NSDQ)
$37.68 USD
-0.15 (-0.40%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $37.70 +0.02 (0.05%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Xenon Pharmaceuticals Inc. [XENE]
Reports for Purchase
Showing records 81 - 100 ( 125 total )
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Die Another Day; ''007 Reduces Seizures in Interim Phase 2 Update
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
XENE Looks To Secure Ex-US Orphan Designation For XEN496
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Delving Virtually Into the Epilepsy Therapeutics Pipeline
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Pipeline Update and Epilepsy Market Overview
Provider: Bloom Burton & Company
Analyst: Research Department
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Notes From The (Virtual) Road... XENE Management Meetings Arrive At Key Time
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
We are transitioning coverage of Xenon Pharmaceuticals Inc. to Antonia Borovina
Provider: Bloom Burton & Company
Analyst: Research Department
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Right On Time, And Moving Quickly - XEN496 Advancing To Phase 3 Studies
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
10-Q Filing Delay Disclosed; COVID-19 Exception Grants Extension
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Progress Despite COVID - Delays Priced In.
Provider: Bloom Burton & Company
Analyst: Research Department
Company: Xenon Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Strange Days Indeed - XENE Provides COVID-19 Updates
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L